(R)-6-((4-Chlorophenyl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-ethynylphenyl)-1-methylquinolin-2(1H)-one

CAS: 1190094-64-4

Ref. 3D-QXB09464

Produktinformation

• Name: (R)-6-((4-Chlorophenyl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-ethynylphenyl)-1-methylquinolin-2(1H)-one
• CAS: 1190094-64-4

Beschreibung

(R)-6-((4-Chlorophenyl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-ethynylphenyl)-1-methylquinolin-2(1H)-one is a farnesyltransferase inhibitor that is being investigated for use in the treatment of cancer. This drug is orally active and has shown good pharmacokinetics. It targets geranylgeranyl transferase, which is involved in the production of proteins that are vital to cell division. The molecular target of (R)-6-((4-Chlorophenyl)(hydroxy)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-ethynylphenyl)-1-- methylquinolin--2(1H)--one is a promising new anticancer agent that can be used in combination with statins to prevent the onset of tumorigenesis. It also

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 480 g/mol
• Formel: C₂₉H₂₂ClN₃O₂
• Reinheit: Min. 95%